Hem › Övervikt › New York › Rochester
Kliniska studier för Övervikt i Rochester, NY
14 studier för Övervikt söker deltagare vid platser i och runt Rochester (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RekryterarFas 3
- Rochester Clinical Research, Rochester
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekryterarFas 3
- Rochester Clinical Research, Rochester
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekryterarFas 2
- Rochester Clinical Research /ID# 282484, Rochester
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RekryterarFas 2
- Rochester Clinical Research, Rochester
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekryterarFas 3
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RekryterarFas 3
- Rochester Clinical Research, LLC, Rochester
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekryterarFas 2
- Rochester Clinical Research, LLC, Rochester
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RekryterarFas 3
- Rochester Clinical Research, LLC, Rochester
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekryterarFas 2
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RekryterarFas 3
- Kailera Clinical Site, Rochester
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RekryterarFas 3
- Rochester Clinical Research, Rochester
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekryterarFas 3
- University of Rochester, Rochester
Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
RekryterarObservationsstudie
- University of Rochester Medical Center, Rochester
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
RekryterarObservationsstudieFriska volontärer välkomna
- Eastman Institute for Oral Health, University of Rochester, Rochester
Övervikt-studier i andra städer
- Houston, TX43 studier
- Chicago, IL41 studier
- New York City, NY40 studier
- San Antonio, TX40 studier
- Washington, DC33 studier
- Orlando, FL32 studier
- Dallas, TX30 studier
- Boston, MA28 studier
- Las Vegas, NV27 studier
- Miami, FL27 studier
- Baltimore, MD26 studier
- Jacksonville, FL25 studier
Andra studier i Rochester
- Akut myeloid leukemi16 studier
- Lungcancer15 studier
- Bröstcancer15 studier
- Cancer (alla typer)14 studier
- Övervikt13 studier
- Icke-småcellig lungcancer13 studier
- Prostatacancer10 studier
- Metastaserande cancer8 studier
- Multipelt myelom8 studier
- Blåscancer7 studier
- Myotonisk dystrofi7 studier
- Bukspottkörtelcancer7 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.